SFG
TEVA icon

SevenBridge Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SevenBridge Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-125
Closed -$1K – 528
2019
Q2 		$1K Hold
125
– – ﹤0.01% 623
2019
Q1 		$2K Hold
125
– – ﹤0.01% 567
2018
Q4 		$2K Hold
125
– – ﹤0.01% 528
2018
Q3 		$3K Hold
125
– – ﹤0.01% 535
2018
Q2 		$3K Hold
125
– – ﹤0.01% 540
2018
Q1 		$2K Hold
125
– – ﹤0.01% 574
2017
Q4 		$2K Hold
125
– – ﹤0.01% 586
2017
Q3 		$2K Hold
125
– – ﹤0.01% 578
2017
Q2 		$4K Hold
125
– – ﹤0.01% 553
2017
Q1 		$4K Sell
125
-4,599
-97% -$157K ﹤0.01% 536
2016
Q4 		$209K Hold
4,724
– – 0.15% 126
2016
Q3 		$209K Buy
4,724
+1,550
+49% +$80.9K 0.15% 126
2016
Q2 		$159K Buy
+3,174
New +$169K 0.11% 158

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

SevenBridge Financial Group's TEVA Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2019, closing a stake of 125 shares — an estimated $1K sold.

SevenBridge Financial Group first reported a position in TEVA in Q2 2016 and held it in 13 quarters. The position peaked at $209K in Q4 2016. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • SevenBridge Financial Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2019 after selling out during the quarter.
  • SevenBridge Financial Group sold 125 Teva Pharmaceutical Industries Limited shares in Q3 2019, an estimated $1K.
  • SevenBridge Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and held it in 13 quarters.
  • SevenBridge Financial Group's Teva Pharmaceutical Industries Limited position peaked at $209K in Q4 2016.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.